PB1866: RESPONSE TO NOVEL ANTI CD20 ANTIBODY AND BCL2 INHIBITOR IN A PATIENT WITH CLL AND MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH LEUKEMIC KIDNEY INFILTRATION AND REVIEW OF LITERATURE

• J. G. Goanta,
• I. Rotaru,
• C. I. Popa,
• A. M. Patrascu

Affiliations

J. G. Goanta

1 Hematology, University of Medicine and Pharmacy, Craiova, Romania

I. Rotaru

1 Hematology, University of Medicine and Pharmacy, Craiova, Romania

C. I. Popa

1 Hematology, University of Medicine and Pharmacy, Craiova, Romania

A. M. Patrascu

1 Hematology, University of Medicine and Pharmacy, Craiova, Romania